Search research articles
Contact Us
Filters
Showing results (121-130 of 272) with videos related to
Page
of 28
Sort By:
Journal of the National Cancer Institute
|
September 11, 2021
Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials
Fabio Efficace, David Cella, Neil K Aaronson, et al.
Journal of Translational Medicine
|
October 22, 2014
The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014
Paolo A Ascierto, Raffaele Addeo, Giacomo Cartenì, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 3, 2024
Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working group
Angela Toss, Claudia Piombino, Paola Quarello, et al.
Tumori
|
February 25, 2026
Patient-reported financial toxicity within Italian public healthcare system: A cross-sectional analysis in patients with cancer
Anna Amela Valsecchi, Pamela Festa, Maria Laura Malgarini, et al.
Critical Reviews in Oncology/Hematology
|
August 31, 2015
Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors
Pasqualina Giordano, Anna Manzo, Agnese Montanino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2009
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer
Massimo Di Maio, Paolo Chiodini, Vassilis Georgoulias, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 12, 2014
Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database
Matan J Cohen, Izhar Levy, Orly Barak, et al.
Expert Review of Anticancer Therapy
|
February 10, 2012
Cetuximab in non-small-cell lung cancer
Guido Carillio, Agnese Montanino, Raffaele Costanzo, et al.
Clinical Lung Cancer
|
May 23, 2016
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer
Cesare Gridelli, Antonio Rossi, Fortunato Ciardiello, et al.
Journal of Clinical Gastroenterology
|
December 19, 2002
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study
Bruno Daniele, Ilario De Sio, Francesco Izzo, et al.
Page
of 28
Search research articles
Search
Showing results (121-130 of 272) with videos related to
Sort By:
Page
of 28
Journal of the National Cancer Institute
|
September 11, 2021
Impact of Blinding on Patient-Reported Outcome Differences Between Treatment Arms in Cancer Randomized Controlled Trials
Fabio Efficace, David Cella, Neil K Aaronson, et al.
Journal of Translational Medicine
|
October 22, 2014
The role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014
Paolo A Ascierto, Raffaele Addeo, Giacomo Cartenì, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 3, 2024
Risk factors behind the increase of early-onset cancer in Italian adolescents and young adults: An investigation from the Italian AYA Working group
Angela Toss, Claudia Piombino, Paola Quarello, et al.
Tumori
|
February 25, 2026
Patient-reported financial toxicity within Italian public healthcare system: A cross-sectional analysis in patients with cancer
Anna Amela Valsecchi, Pamela Festa, Maria Laura Malgarini, et al.
Critical Reviews in Oncology/Hematology
|
August 31, 2015
Afatinib: An overview of its clinical development in non-small-cell lung cancer and other tumors
Pasqualina Giordano, Anna Manzo, Agnese Montanino, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 11, 2009
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer
Massimo Di Maio, Paolo Chiodini, Vassilis Georgoulias, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
February 12, 2014
Trans-arterial chemo-embolization is safe and effective for elderly advanced hepatocellular carcinoma patients: results from an international database
Matan J Cohen, Izhar Levy, Orly Barak, et al.
Expert Review of Anticancer Therapy
|
February 10, 2012
Cetuximab in non-small-cell lung cancer
Guido Carillio, Agnese Montanino, Raffaele Costanzo, et al.
Clinical Lung Cancer
|
May 23, 2016
BEVERLY: Rationale and Design of a Randomized Open-Label Phase III Trial Comparing Bevacizumab Plus Erlotinib Versus Erlotinib Alone as First-Line Treatment of Patients With EGFR-Mutated Advanced Nonsquamous Non-Small-Cell Lung Cancer
Cesare Gridelli, Antonio Rossi, Fortunato Ciardiello, et al.
Journal of Clinical Gastroenterology
|
December 19, 2002
Hepatic resection and percutaneous ethanol injection as treatments of small hepatocellular carcinoma: a Cancer of the Liver Italian Program (CLIP 08) retrospective case-control study
Bruno Daniele, Ilario De Sio, Francesco Izzo, et al.
Page
of 28